WHO ICTRP trial
EMAT Study
JPRN-jRCTs052220170 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs052220170 |
|---|---|
| Public title | EMAT Study |
| Scientific title | The Effect of repetitive transcranial Magnetic stimulation on patients with Autism spectrum disorder and Traumatic symptoms: a double-blind, randomized, sham-controlled Phase II study |
| Primary sponsor | Ikawa Daisuke |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Autism spectrum disorder |
| Interventions | Repetitive transcranial magnetic stimulation |
| Registration date | Feb 15, 2023 |
| Target size | 30 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: